alexa Role of Specific Cancer Treatments in Pain Management | Open Access Journals
ISSN: 2329-6771
Journal of Integrative Oncology
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Role of Specific Cancer Treatments in Pain Management

Sidy KA1*, Doudou Diouf2, Rokhaya Desirée Niang2, Adja Coumba Diallo1, Mamadou Moustapha Dieng3, Pape Macoumba Gaye3 and Ahmadou Dem1

1Department of Surgical oncology, Joliot Curie Cancer Institute, Dakar, Senegal

2Depatment of Medical oncology, Joliot Curie Cancer Institute, Dakar, Senegal

3Department of Radiotherapy, Joliot Curie Cancer Institute, Dakar, Senegal

*Corresponding Author:
Sidy KA
Surgical oncologist, Joliot Curie Cancer Institute, Dakar, Senegal
Tel: +33 01 56 24 55 00
E-mail: kasidy@hotmail.com

Received date: February 06, 2017; Accepted date: February 17, 2017; Published date: February 27, 2017

Citation: Sidy KA, Diouf D, Niang RD, Diallo AC, Dieng MM, et al. (2017) Role of Specific Cancer Treatments in Pain Management. J Integr Oncol 6:186. doi: 10.4172/2329-6771.1000186

Copyright: © 2017, Sidy KA. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Integrative Oncology

Commentary

Cancer is characterized by tissue invasion leading to destruction, inflammation, irritation, obstructions and compressions. All these causes of pain may be present in varying degrees in all stages. The pain management therefore depends on the management of cancer and vice versa.

The tissue destruction is the rule in cancers of solid organs and bones, in primitive or metastatic circumstances. Liver cancers reach large dimensions, cause destruction, necrosis, inflammation, bleeding and compression. Pain is typically multifactorial. The management of this pain uses different levels of treatment from paracetamol to morphine derivatives and morphine [1]. Specific treatments involved in the control of pain indirectly during disease control or directly in the control of mainly secondary lesions. This is the case of radiotherapy for brain metastases. The diagnosis of metastasis is made by CT or MRI front of cranial hypertension syndrome. The effects of radiation are tumoricidal, anti-inflammatory, decongestant, but also for consolidation and neurological decompression. Its analgesic efficacy is very important. The use of an intrathecal pump-delivered infusion in selected patients should be a complementary option [2].

Bone tumors, secondary more often than primary, indicative of cancers because of the pain offer a wider choice of treatment. Even if at this stage healing is impossible. The treatment is based on non-specific tools such as analgesics, bisphosphonates, cementoplasty and physiotherapy but also specific tools such as radiotherapy. Zoledronic acid and denosumab remain a safe and efficient choice in aggressive non metastatic post-menopausal breast cancer patients and for bone metastatic patients [3]. Radiotherapy plays a fundamental role with remarkable analgesic efficacy in pain associated with bone metastasis in general and in particular in spinal metastases for 30 to 80% of patients [4]. In this field new therapeutic findings as Strontium-89 are very promising in pain control particularly in resistant specific treatment such as castration in prostate cancer [5].

Inflammatory cancer is a common condition. Cancer has the ability to induce inflammation by genetic way, infection and tumor progression. Inflammatory breast cancer and obstructive or ulcerative cancers are good illustrations. Chemotherapy, hormone therapy or targeted therapies are at the forefront of the treatment of pain. Surgery by lifting obstacles and removing lesions plays an indirect role [6].

Pain can be specific to the organ due to its structure, operation, anatomical position and innervation [7]. Pain evokes the diagnosis. Pancreatic cancer is a particular example. The solar type of pain is typical. The treatment for this pain is difficult. Opioids are ineffective and surgery is limited by the late discovery of the tumor, the anatomic position and depth of the organ. Chemotherapy and chemo radiation therapy are not effective [8]. Surgical and CT guided block by alcohol appliance or splanchnic neurotomy in the case of pancreatic cancer and neurotomy and neurostimulation in other cases often remains last resorts [9].

Specific cancer treatments such as surgery, radiation therapy and medical treatments offer considerable benefits in the treatment of cancer pain. Depending on the type of cancer the combination with analgesics is done differently and at different levels. Their action is essential in the range of therapeutic choices.

References

Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 151
  • [From(publication date):
    February-2017 - Apr 27, 2017]
  • Breakdown by view type
  • HTML page views : 128
  • PDF downloads :23
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version